Experiencia clínica y urodinámica con ácido hialurónico intravesical en el síndrome de vejiga dolorosa asociado a cistitis intersticial

Figueiredo, A. B; Palma, P; Riccetto, C; Herrmann, V; Dambros, M; Capmartin, R.
Actas urol. esp ; 35(3): 184-187, mar. 2011. tab
Artículo en Español | IBECS (España) | ID: ibc-88447

Documentos relacionados

  1. Minimally invasive device for intravesical instillation by urological syringe adapter (MID-ii U.S.A.) for catheter-free instillation therapy of the bladder in interstitial cystitis/bladder pain syndrome.
  2. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
  3. Breaking the cycle of pain in interstitial cystitis/painful bladder syndrome: toward standardization of early diagnosis and treatment: consensus panel recommendations.
  4. Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis.
  5. Interventional therapies for controlling pelvic pain: what is the evidence?
  6. Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies.
  7. Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis.
  8. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
  9. A novel highly effective treatment of interstitial cystitis causing chronic pelvic pain of bladder origin: case reports.
  10. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].